XML 210 R41.htm IDEA: XBRL DOCUMENT v3.25.4
SHAREHOLDERS’ EQUITY (DEFICIT) (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2025
Dec. 31, 2024
Equity [Abstract]    
SCHEDULE OF STOCK OPTION ACTIVITY

Stock option activity for the periods presented is as follows:

 

   Options  

Weighted

Average

Exercise Price

Per Share

  

Weighted

Average

Remaining

Contractual

Term (years)

 
Outstanding at December 31, 2024   18,614   $5.59    7.5 
Granted             
Cancelled   (848)   20.30      
Exercised             
Outstanding as of September 30, 2025   17,766   $5.57    6.7 
Exercisable as of September 30, 2025   16,144   $4.81      

The balance and activity of all stock options outstanding as of December 31, 2024, and 2023, is as follows:

 

   Options  

Weighted

Average

Exercise Price

Per Share

  

Weighted

Average

Remaining

Contractual

Term (years)

 
Outstanding at December 31, 2022   100,305   $3.50    9.4 
Granted   15,309   $205.25      
Cancelled   (12,551)  $5.50      
Exercised   (8,296)  $3.00      
Outstanding at December 31, 2023   94,767   $35.75    8.8 
Granted   34,370   $12.76      
Cancelled   (77,910)  $43.57      
Exercised   (32,613)  $3.63      
Outstanding as of December 31, 2024   18,614   $5.59    7.5 
Exercisable as of December 31, 2024   15,360   $4.03      
SCHEDULE OF RESTRICTED STOCK UNIT

Restricted stock unit activity for the period presented is as follows:

 

   Restricted Stock Units   Weighted Average Grant Date Fair Value 
Outstanding at December 31, 2024   29,080   $18.75 
Granted   358,397    1.83 
Vested   (340,154)   2.85 
Forfeited        
Outstanding as of September 30, 2025   47,323   $4.87 

Restricted stock unit activity for the period presented is as follows:

 

   Restricted
Stock Units
   Weighted Average
Grant Date Fair Value
 
Outstanding at December 31, 2023      $ 
Granted   65,171    16.47 
Vested   (7,355)   18.75 
Forfeited   (28,736)   18.75 
Outstanding at December 31, 2024   29,080   $13.64 
SCHEDULE OF AUTHORIZED STOCK  

The Company has authorized stock which have been designated as follows:

 

  

Number of Shares

Authorized

  

Number of Shares

Outstanding As of

December 31, 2024

   Par Value 
Class A Common Stock   200,000,000    1,843,852   $0.0001 
Preferred Stock   1,000,000       $0.0001 
SCHEDULE OF ALL STOCK OPTIONS OUTSTANDING  

The following table summarizes the range of exercise price, weighted average remaining contractual life (“Life”) and weighted average exercise price (“Price”) for all stock options outstanding as of December 31, 2024:

 

      Options Outstanding  
Exercise Price     Shares     Life (in years)  
$ 3.00       1,763       6.6  
$ 3.50       13,562       7.2  
$ 12.50       3,230       9.4  
$ 177.75       44       0.0  
$ 210.00       15       5.4  
          18,614       7.5  
SCHEDULE OF WEIGHTED-AVERAGE ASSUMPTIONS  

The fair value of stock options on the grant date was determined using the following weighted-average assumptions during the year ended December 31, 2024 and 2023:

 

   For The Year Ending December 31, 
   2024   2023 
Expected term   5.8 - 6.25 years    2-6 years 
Expected volatility   68%    30% - 71% 
Expected dividends   None    None 
Risk-free interest rate   3.8% - 4.5%    3.6%-4.6% 
Forfeitures   None    None 
SCHEDULE OF COMPANY’S WARRANT ACTIVITY  

The following table is a summary of the Company’s warrant activity during the years ended December 31, 2024:

 

   Warrants  

Weighted

Average

Exercise Price

Per Share

  

Weighted

Average

Remaining

Contractual

Term (years)

 
Outstanding as of January 1, 2023   1,161,195   $287.50    5 
Granted              
Cancelled              
Exercised              
Outstanding as of December 31, 2024   1,161,195   $287.50    3.92 years 
Exercisable as of December 31, 2024   1,161,195